Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Person
|
| gptkbp:advocacy |
vaccine education programs
|
| gptkbp:advocates_for |
vaccination awareness
|
| gptkbp:affiliation |
gptkb:University_of_Pennsylvania
|
| gptkbp:award |
gptkb:Lasker_Award
|
| gptkbp:birth_place |
gptkb:United_States
|
| gptkbp:birth_year |
gptkb:1961
|
| gptkbp:collaboration |
academic institutions
biotechnology companies |
| gptkbp:collaborations |
non-profit organizations
pharmaceutical companies global health organizations international research projects |
| gptkbp:collaborator |
gptkb:Katalin_Karikó
|
| gptkbp:community_outreach |
community health initiatives
|
| gptkbp:contribution |
vaccine research funding
vaccine technology vaccine safety studies vaccine distribution strategies advancements in immunology advancements in vaccine technology lipid nanoparticles in m RNA delivery |
| gptkbp:education |
gptkb:University_of_Pennsylvania
|
| gptkbp:field |
immunology
|
| gptkbp:funding |
government grants
|
| gptkbp:goal |
pandemic preparedness
improving vaccine efficacy |
| gptkbp:has_experience_in |
vaccine development
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dr. Drew Weissman
|
| gptkbp:impact |
public health improvements
global health vaccine accessibility immunization rates |
| gptkbp:influence |
gptkb:Health_Insurance
|
| gptkbp:influenced |
COVID-19 vaccine development
|
| gptkbp:innovation |
m RNA technology advancements
new vaccine platforms novel delivery systems |
| gptkbp:invention |
m RNA technology
|
| gptkbp:involvement |
COVID-19 vaccine trials
|
| gptkbp:known_for |
m RNA vaccine research
|
| gptkbp:leadership |
research teams
|
| gptkbp:media_appearances |
interviews on vaccine science
|
| gptkbp:mentor |
young researchers
scientists in m RNA research |
| gptkbp:nationality |
gptkb:American
|
| gptkbp:public_speaking |
scientific conferences
|
| gptkbp:publication |
gptkb:Nature
gptkb:Proceedings_of_the_National_Academy_of_Sciences gptkb:Science gptkb:Cell clinical trial results |
| gptkbp:publications |
peer-reviewed journals
|
| gptkbp:recognition |
gptkb:scientific_community
|
| gptkbp:research |
molecular biology techniques
|
| gptkbp:research_areas |
infectious diseases
|
| gptkbp:research_focus |
RNA biology
therapeutic vaccines vaccine response mechanisms |
| gptkbp:research_institutes |
gptkb:Perelman_School_of_Medicine
|
| gptkbp:research_output |
improved public health outcomes
successful vaccine trials |
| gptkbp:role |
scientific advisor
|
| gptkbp:scientific_classification |
awards and honors
international awards |
| gptkbp:bfsParent |
gptkb:La_Jolla,_California
|
| gptkbp:bfsLayer |
4
|